RNRCTJournal of the American Medical Directors Association2022

Disease Management in Skilled Nursing Facilities Improves Outcomes for Patients With a Primary Diagnosis of Heart Failure.

Himali Weerahandi, Erin L Chaussee, John A Dodson and 2 others

PMID 34478693

WHAT IT FOUND

In skilled nursing facilities, a nurse-led heart failure program reduced 60-day hospitalization, emergency visits, or death in patients admitted primarily for heart failure.

The intervention lowered mortality to zero compared to 14.7% in usual care. This was a small subgroup analysis.

Key findings

01The composite rate of rehospitalization, ED visits, and mortality at 60 days was significantly lower in the intervention group (30%) compared to usual care (52%).

0260-day mortality was significantly lower in the intervention group (0%) compared to usual care (14.7%).

03Adherence to medication titration recommendations made by the nurse advocate was low, with only 24% followed by clinicians.

STILL TO COME

How it was doneWhat they foundWhat it means for RNs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

This was a post-hoc subgroup analysis, not the primary outcome of the larger trial, which was null. The sample size was small (125 patients), making the results susceptible to chance. The intervention was multifaceted, so it is unclear which specific component (e.g., education vs. monitoring) drove the benefit. Low adherence to medication recommendations suggests the observed benefit may not be due to pharmacological optimization alone.

Declared interests

The authors declared no conflicts of interest. The study was supported by the National Institutes of Health.

The easy way to misread this

Do not assume this intervention works for all heart failure patients in skilled nursing facilities. The benefit was only seen in the specific subgroup with a primary hospital diagnosis of heart failure, and the parent trial showed no significant difference in the composite outcome for the broader population.

Read it on PubMed →